Bristol-Myers Squibb and Denmark’s Nordic Bioscience inked a deal to develop biomarker technology to diagnose and monitor nonalcoholic steatohepatitis.
Abbott and Alere agreed on a new price of $5.3 billion for their deal and to dismiss their respective lawsuits.
It’s a critical tradeoff for life. Our bodies use sugar and fat from the food we consume to produce energy in our cells’ mitochondria, the internal powerhouses…
ALung Technologies raised $36 million to trial its artificial lung technology for patients with respiratory failure.
Johnson & Johnson unit Codman Neuro has picked up privately held Galway, Ireland-based stroke care company Neuravi for an undisclosed price, giving J&J…
After Theranos offered to trade shares to investors for promises not to sue, it turns out Holmes is about $25 million in debt to her company.
ArcherDX and HeliTec are teaming up to develop NGS-based cancer diagnostics in China.
Cancer Genetics has tapped Mendel Health for help matching patients to oncology clinical trials.
B. Braun and Philips have teamed up to work on ultrasound-guided regional anesthesia products.
Philips is partnering with PathAI to improve the speed and accuracy of cancer diagnosis.
Boston Scientific will pony up $435 million upfront to acquire Switzerland’s Symetis, which makes TAVI devices.